Corinne Hanotin

Summary

Affiliation: CHU de Nancy
Country: France

Publications

  1. ncbi Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients
    B Guerci
    Centre d Investigation Clinique INSERM Centre Hospitalier Universitaire de NANCY Hôpital Jeanne d Arc, Toul, France
    J Clin Endocrinol Metab 84:2673-8. 1999
  2. ncbi Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators
    F Zannad
    Department of Cardiology, Centre d Investigation Clinique INSERM CHU, University Henri Poincare, Nancy, France
    Am Heart J 136:672-80. 1998
  3. ncbi Genetics of intima-media thickness
    Faiez Zannad
    Department of Cardiovascular Disease, Division of Hypertension and Preventive Cardiology, Equipe d Accueil 3447, Clinical Investigation Center INSERM CHU, University Henri Poincare, Nancy, France
    Curr Opin Lipidol 14:191-200. 2003
  4. ncbi FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics
    Faiez Zannad
    Hypertension and Preventive Cardiology Division, Department of Cardiovascular Disease, and Centre d Investigations Cliniques INSERM CHU, Toul, France
    Fundam Clin Pharmacol 16:353-60. 2002
  5. ncbi Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction
    Faiez Zannad
    Centre d Investigation Clinique INSERM, CHU de Nancy, Hopital Jeanne d Arc, Toul, France
    Am Heart J 144:508-15. 2002
  6. ncbi Environmental and genetic determinants of intima-media thickness of the carotid artery
    F Zannad
    Centre d Investigation Clinique INSERM CHU de Nancy, France
    Clin Exp Pharmacol Physiol 28:1007-10. 2001
  7. ncbi Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators
    F Zannad
    Centre d Investigation Clinique INSERM CHU, Laboratory of Biochemistry, Centre Hospitalier Universitaire, University Henri Poincare, Nancy, France
    Circulation 102:2700-6. 2000
  8. ncbi Ambulatory 24-h blood pressure assessment of the felodipine-metoprolol combination versus amlodipine in mild to moderate hypertension. Lorraine General Physician Investigators Group
    F Zannad
    centre d investigation clinique, INSERM CHU, Nancy, France
    J Hypertens 17:1023-32. 1999
  9. ncbi Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine
    F Zannad
    Cardiology Department, centre d investigation clinique, INSERM CHU, Nancy, France
    J Am Coll Cardiol 33:734-42. 1999
  10. ncbi Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study
    Luc F Van Gaal
    Department of Diabetology, Metabolism, and Clinical Nutrition, Antwerp University Hospital, Wilrijkstraat 10, B 2650 Edegem Antwerp, Belgium
    Eur Heart J 29:1761-71. 2008

Detail Information

Publications10

  1. ncbi Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients
    B Guerci
    Centre d Investigation Clinique INSERM Centre Hospitalier Universitaire de NANCY Hôpital Jeanne d Arc, Toul, France
    J Clin Endocrinol Metab 84:2673-8. 1999
    ..Thus, a short interruption of Lispro in CSII is associated with an earlier, greater metabolic deterioration, but Lispro corrected this metabolic deterioration more effectively...
  2. ncbi Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators
    F Zannad
    Department of Cardiology, Centre d Investigation Clinique INSERM CHU, University Henri Poincare, Nancy, France
    Am Heart J 136:672-80. 1998
    ....
  3. ncbi Genetics of intima-media thickness
    Faiez Zannad
    Department of Cardiovascular Disease, Division of Hypertension and Preventive Cardiology, Equipe d Accueil 3447, Clinical Investigation Center INSERM CHU, University Henri Poincare, Nancy, France
    Curr Opin Lipidol 14:191-200. 2003
    ..The aim of this paper is to review the most recent available data on the genetic determinants of carotid intima-media thickness...
  4. ncbi FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics
    Faiez Zannad
    Hypertension and Preventive Cardiology Division, Department of Cardiovascular Disease, and Centre d Investigations Cliniques INSERM CHU, Toul, France
    Fundam Clin Pharmacol 16:353-60. 2002
    ..All patients were included by December 2000 and follow-up is ongoing. The last visit for the last patient is scheduled for 30 December 2002. We report here on the study design and the baseline characteristics of the study population...
  5. ncbi Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction
    Faiez Zannad
    Centre d Investigation Clinique INSERM, CHU de Nancy, Hopital Jeanne d Arc, Toul, France
    Am Heart J 144:508-15. 2002
    ..In obese subjects, weight reduction regresses LV mass (LVM), regardless of blood pressure. Sibutramine can increase blood pressure and heart rate, which may attenuate the reductions in LVM associated with weight loss...
  6. ncbi Environmental and genetic determinants of intima-media thickness of the carotid artery
    F Zannad
    Centre d Investigation Clinique INSERM CHU de Nancy, France
    Clin Exp Pharmacol Physiol 28:1007-10. 2001
    ..8. In women, none of the studied polymorphisms was associated with CIMT variation. 9. Our study gives new perspectives for understanding CIMT variability in healthy middle-aged subjects...
  7. ncbi Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators
    F Zannad
    Centre d Investigation Clinique INSERM CHU, Laboratory of Biochemistry, Centre Hospitalier Universitaire, University Henri Poincare, Nancy, France
    Circulation 102:2700-6. 2000
    ..It has been suggested that spironolactone may decrease cardiac fibrosis. We investigated the interactions between serum markers of cardiac fibrosis and the effect of spironolactone on outcome in patients with CHF...
  8. ncbi Ambulatory 24-h blood pressure assessment of the felodipine-metoprolol combination versus amlodipine in mild to moderate hypertension. Lorraine General Physician Investigators Group
    F Zannad
    centre d investigation clinique, INSERM CHU, Nancy, France
    J Hypertens 17:1023-32. 1999
    ....
  9. ncbi Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine
    F Zannad
    Cardiology Department, centre d investigation clinique, INSERM CHU, Nancy, France
    J Am Coll Cardiol 33:734-42. 1999
    ..Characterize the incidence, clinical and etiologic features and outcomes of advanced congestive heart failure...
  10. ncbi Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study
    Luc F Van Gaal
    Department of Diabetology, Metabolism, and Clinical Nutrition, Antwerp University Hospital, Wilrijkstraat 10, B 2650 Edegem Antwerp, Belgium
    Eur Heart J 29:1761-71. 2008
    ..We report the 2 year efficacy and tolerability data of rimonabant...